Holy fire in an HIV-positive man: a case of 21st-century ergotism.
Fröhlich
Georg
G
Department of Internal Medicine, Clinic for Angiology, University Hospital Zurich, Zurich, Switzerland. GeorgMarcus.Froehlich@usz.ch
Kaplan
Vladimir
V
Amann-Vesti
Beatrice
B
D000328:Adult; D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D000925:Anticoagulants / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D004878:Ergotamine / Q000009:adverse effects*; D004881:Ergotism / Q000150:complications* / Q000188:drug therapy / Q000209:etiology*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007511:Ischemia / Q000188:drug therapy; D008297:Male; D005996:Nitroglycerin / Q000627:therapeutic use; D034941:Upper Extremity / Q000098:blood supply / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use
D044966:Anti-Retroviral Agents; D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014665:Vasodilator Agents; D011464:Epoprostenol; D005996:Nitroglycerin; D004878:Ergotamine